Israel’s Equinom raises USD 35 million for new non-GMO plant protein ingredients
Categories: Hi-Tech
High-tech optimized crop breeder Equinom has raised USD 35 million in a funding round, nearly doubling the company’s lifetime funding to USD 71 million.
Israel-based Equinom is one of a handful of companies using technology to breed better crops for food. All of Equinom’s ingredients are non-GMO and bred using traditional processes.
The round was led by Synthesis Capital, and had participation from Bunge Ventures, Praesidium, BayWa, CPT Capital and returning investors Fortissimo and Phoenix.
The funds will be used to get Equinom’s plant-based protein ingredients to a B2B market more quickly.
